Ralmac (Raltegravir 400 mg Tablets) is an antiretroviral medicine used in combination therapy for the treatment of HIV-1 infection.
| Composition | Raltegravir |
| Manufacturer | McNeil & ARGUS |
| Packing | 60 Tablets |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenolam E Tablet is a combination of three HIV medications: efavirenz (600 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg), and it is used to treat HIV-1 infection in adults and teenagers.
| Composition | Efavirenz 600mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300 mg |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Xapavir 50mg Tablet contains Dolutegravir, an antiretroviral medication used in the treatment of HIV-1 infection. It belongs to the class of drugs known as integrase strand transfer inhibitors (INSTIs).
| Composition | Dolutegravir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Inbec Tablet is a fixed-dose combination of Abacavir (600mg), Dolutegravir (50mg), and Lamivudine (300mg), used in the treatment of HIV-1 infection in adults and adolescents.
| Composition | Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Strip |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Raltegravir 400mg Tablet is used as part of antiretroviral therapy (ART) to treat HIV-1 infection. It helps lower the viral load and improve immune system function.
| Composition | Raltegravir 400mg |
| Manufacturer | McNeil & ARGUS |
| Packing | 60 Tablets |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Spegra Tablet is a once-daily antiretroviral medication used to treat HIV-1 infection in adults. It combines three powerful ingredients Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) to effectively suppress the HIV virus, reduce its ability to multiply, and strengthen the immune system.
| Composition | Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Tafero EM Tablet is a combination of Tenofovir Alafenamide 25 mg and Emtricitabine 200 mg, used for the treatment and prevention of HIV-1 infection.
| Composition | Tenofovir Alafenamide 25 mg + Emtricitabine (200 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenof EM Tablet contains two antiretroviral medicines: emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg), and it is used to treat and prevent HIV-1 infection in adults and teenagers.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenvir-EM Tablet is a combination of Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg), used in the treatment and prevention of HIV-1 infection.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tudobest 300 mg Tablet contains Tenofovir Disoproxil Fumarate, an antiretroviral medication used in the treatment of HIV-1 infection and chronic hepatitis B virus (HBV) infection.
| Composition | Tenofovir Disoproxil Fumarate |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Twinaqt Tablet is a combination antiretroviral medication containing Dolutegravir (50 mg) and Lamivudine (300 mg). It is used for the treatment of HIV-1 infection in adults and adolescents.
| Composition | Dolutegravir 50mg + Lamivudine 300mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in a Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Viropil Tablet is a fixed-dose antiretroviral combination containing Dolutegravir (50 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg). It is used in the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg.
| Composition | Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Efavir 600 Tablet contains Efavirenz 600 mg, an antiretroviral medicine used in the treatment of HIV-1 infection. It works by blocking the reverse transcriptase enzyme, which the HIV virus needs to multiply.
| Composition | Efavirenz 600 mg |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV infection |
| Expiry | December 2027 |
